Consensus EPS · Q2 2026
$1.98
Consensus revenue · Q2 2026
$6.3B
Analysts
9
Last reported
Jul 23, 2026
Analyst consensus
Based on estimates from 9 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $6.1B | $6.3B | $6.7B |
| EPS | $1.84 | $1.98 | $2.17 |
| EBITDA | $2.5B | $2.5B | $2.5B |
| EBIT | $1B | $1B | $1B |
| Net income | $2B | $2.1B | $2.3B |
- Revenue$6.3B
- EPS$1.98
- EBITDA$2.5B
- EBIT$1B
- Net income$2.1B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q2 2026 | $6.1B | $6.4B | -3.7% | $2.10 | $1.99 | +5.4% |
| Q1 2026 | $7.3B | $6.6B | +11.2% | $2.90 | $2.18 | +32.8% |
| Q4 2025 | $7.1B | $6.2B | +14.6% | $2.52 | $2.07 | +21.9% |
- Q2 2026-3.7%+5.4%
- Q1 2026+11.2%+32.8%
- Q4 2025+14.6%+21.9%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
No community consensus
No TickerLeague members predicted Newmont (NEM) Q2 2026 before it reported.
Analyst price target
Based on price targets from 5 analysts.
- Low
- $120.00
- Consensus
- $142.70
- Median
- $140.00
- High
- $175.00
- Current
- $93.19
- Upside
- +53.1%
Upside calculated vs most recent trading price of $93.19.
Analyst ratings
Consensus: Buy — based on 37 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 16, 2026 | Barclays | maintain | Overweight | Overweight |
| Jul 14, 2026 | TD Cowen | upgrade | Hold | Buy |
| Jul 14, 2026 | Scotiabank | maintain | Sector Outperform | Sector Outperform |
| Jul 9, 2026 | RBC Capital | maintain | Outperform | Outperform |
| Jul 9, 2026 | B of A Securities | maintain | Buy | Buy |
| Jul 6, 2026 | Jefferies | maintain | Buy | Buy |
| Jun 30, 2026 | UBS | maintain | Buy | Buy |
| Apr 24, 2026 | BMO Capital | maintain | Outperform | Outperform |
| Apr 21, 2026 | CIBC | maintain | Outperform | Outperform |
| Mar 27, 2026 | UBS | maintain | Buy | Buy |
- Jul 16, 2026BarclaysOverweight
- Jul 14, 2026TD CowenBuy
- Jul 14, 2026ScotiabankSector Outperform
- Jul 9, 2026RBC CapitalOutperform
- Jul 9, 2026B of A SecuritiesBuy
- Jul 6, 2026JefferiesBuy
- Jun 30, 2026UBSBuy
- Apr 24, 2026BMO CapitalOutperform
- Apr 21, 2026CIBCOutperform
- Mar 27, 2026UBSBuy
Frequently asked questions
Newmont (NEM) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks4.43% TTM
- Dividend Profile1.09% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History3 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.